Dr. Nina Yin, graduated from National School of Development, Peking University, received her Ph.D. in Economics from Toulouse School of Economics in September 2013 and was a postdoctoral fellow at Tulane University. Her broader research interests include health economics, industrial organization, and economics of innovation and intellectual property rights. Her research has focused on understanding the effects of pharmaceutical regulation, the pharmaceutical manufacturers' strategic behaviors (i.e., pricing, innovating and advertising) and the welfare effects on patients. For example, the pros and cons of granting market exclusivity to incremental innovations on pharmaceuticals, how the newly discovered clinical information affect physicians’ prescription behaviors. Her research has been published in Health Economics, Economics Letters, American Journal of Health Economics, China Economic Review, The Oxford Handbook of Venture Capital, etc. She has been invited for presentation at international conferences in industrial organization and health economics, such as IIOC, EARIE, and ASHEcon, etc.